CHICAGO TRUST Co NA bought a new position in Ambev S.A. (NYSE:ABEV – Free Report) during the second quarter, Holdings Channel reports. The fund bought 62,805 shares of the company’s stock, valued at approximately $129,000.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Raymond James & Associates boosted its stake in Ambev by 7.1% in the 4th quarter. Raymond James & Associates now owns 1,133,135 shares of the company’s stock worth $3,173,000 after purchasing an additional 75,149 shares in the last quarter. International Assets Investment Management LLC boosted its stake in Ambev by 180.0% in the 4th quarter. International Assets Investment Management LLC now owns 36,204 shares of the company’s stock worth $1,010,000 after purchasing an additional 23,274 shares in the last quarter. Sequoia Financial Advisors LLC boosted its stake in Ambev by 339.1% in the 4th quarter. Sequoia Financial Advisors LLC now owns 688,909 shares of the company’s stock worth $1,944,000 after purchasing an additional 532,012 shares in the last quarter. Cerity Partners LLC boosted its stake in Ambev by 199.6% in the 4th quarter. Cerity Partners LLC now owns 66,735 shares of the company’s stock worth $186,000 after purchasing an additional 44,460 shares in the last quarter. Finally, Sapient Capital LLC bought a new position in Ambev in the 4th quarter worth about $94,000. 8.13% of the stock is owned by hedge funds and other institutional investors.
Ambev Stock Performance
Ambev stock traded up $0.02 during midday trading on Friday, hitting $2.27. The stock had a trading volume of 11,299,445 shares, compared to its average volume of 15,455,054. The firm’s fifty day moving average is $2.12 and its two-hundred day moving average is $2.34. The company has a market capitalization of $35.76 billion, a PE ratio of 11.95, a P/E/G ratio of 3.14 and a beta of 1.06. Ambev S.A. has a 52-week low of $2.01 and a 52-week high of $3.00. The company has a current ratio of 0.99, a quick ratio of 0.69 and a debt-to-equity ratio of 0.02.
Analyst Ratings Changes
A number of equities analysts recently issued reports on ABEV shares. StockNews.com cut shares of Ambev from a “strong-buy” rating to a “buy” rating in a research note on Thursday. Barclays dropped their price target on shares of Ambev from $3.00 to $2.50 and set an “equal weight” rating on the stock in a research note on Thursday, May 9th. Finally, UBS Group lowered their target price on shares of Ambev from $3.20 to $2.90 and set a “buy” rating on the stock in a research note on Wednesday, July 31st. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat, Ambev presently has a consensus rating of “Hold” and a consensus target price of $2.75.
View Our Latest Research Report on Ambev
About Ambev
Ambev SA, through its subsidiaries, engages in the production, distribution, and sale of beer, draft beer, carbonated soft drinks, other non-alcoholic beverages, malt, and food products. It offers beer primarily under the Skol, Brahma, Antarctica, Brahva, Budweiser, Bud Light, Beck, Leffe and Hoegaarden, Bucanero, Cristal, Mayabe, Presidente, Presidente Light, Brahma Light, Bohemia, The One, Corona, Modelo Especial, Stella Artois, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith's, and Kokanee brands.
Recommended Stories
- Five stocks we like better than Ambev
- High Flyers: 3 Natural Gas Stocks for March 2022
- MarketBeat Week in Review – 8/5 – 8/9
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
- What is the Nikkei 225 index?
- The Cannabis Sector: Profitability Takes Center Stage
Want to see what other hedge funds are holding ABEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ambev S.A. (NYSE:ABEV – Free Report).
Receive News & Ratings for Ambev Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambev and related companies with MarketBeat.com's FREE daily email newsletter.